3.16
0.64%
0.02
アフターアワーズ:
3.16
Akari Therapeutics Plc Adr (AKTX) 最新ニュース
Akari Therapeutics PlcADR (AKTX) Price Target Increased by 45.45% to 81.60 - MSN
Akari Therapeutics appoints Rob Bazemore to board - Investing.com
Rob Bazemore Appointed to the Board of Directors of Akari Therapeutics - StockTitan
Akari Therapeutics Receives Positive and Constructive Pre-IND Feedback from US FDA for PAS-nomacopan in Treatment of Geographic Atrophy - StockTitan
Akari Therapeutics shareholders approve board and auditors - Investing.com India
Akari Therapeutics shareholders approve board and auditors By Investing.com - Investing.com India
Zoomcar announces departure of President Adarsh Menon By Investing.com - Investing.com
Phillips Edison expands board, appoints Devin Murphy By Investing.com - Investing.com India
Goldman Sachs raises Birkenstock target to $59.50, keeps neutral stance By Investing.com - Investing.com
Akari Therapeutics shareholders approve board and auditors By Investing.com - Investing.com
Shopify’s market position 'promising for growth', Evercore ISI sees stock upside - Investing.com
Akari Therapeutics secures $7.6 million in private financing By Investing.com - Investing.com
Akari Therapeutics secures $7.6 million in private financing By Investing.com - Investing.com UK
Closing Figures Unveiled: Akari Therapeutics Plc ADR (AKTX) Drop -4.19, Closes at 1.72 – DWinneX - The Dwinnex
Arbe Robotics sees high demand for convertible debt By Investing.com - Investing.com
Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights - GlobeNewswire Inc.
Insmed executive sells over $270k in company stock By Investing.com - Investing.com
Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics - GlobeNewswire Inc.
Dialing Up Nights Out: Heineken® & Bodega Launch the No-Frills 'Boring Phone' | GlobeNewswire by notified - NTB Kommunikasjon
Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights - GlobeNewswire Inc.
India opposition asks Modi government to question Foxconn hiring practices By Reuters - Investing.com
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer I - Benzinga
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Markets Insider
AKTXAkari Therapeutics plc ADR (0.01 USD) Latest Stock News & Market Updates - StockTitan
The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Sh - Benzinga
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 T - Benzinga
48 Stocks Moving In Friday's Mid-Day SessionAfya (NASDAQ:AFYA) - Benzinga
GCI: Best & Worst Performing Small Cap Stocks for July 19, 2019 - StockNews.com
52 Biggest Movers From YesterdayAyala Pharmaceuticals (OTC:ADXS), Altisource Asset Mgmt (AMEX:AAMC) - Benzinga
'Flying Whale' Blimp That Never Lands Joins Global Airship Race - Bloomberg
CRISPR Therapeutics (CRSP) Jumps: Stock Rises 12.1% - Investing.com
22 Stocks Moving In Monday's Pre-Market SessionAkari Therapeutics (NASDAQ:AKTX), argenx (NASDAQ:ARGX) - Benzinga
Mid-Morning Market Update: Markets Fall; Initial Jobless Claims Drop to 259,000Akari Therapeutics (NAS - Benzinga
25 Stocks Moving In Tuesday's Pre-Market SessionAkari Therapeutics (NASDAQ:AKTX), Aurinia Pharmaceutic - Benzinga
Mid-Afternoon Market Update: Dow Drops 50 Points; TRC Companies Shares Spike Higher - Nasdaq
Lockheed Lands Airship Deal as Oil Industry Spurs Blimp Revival - Bloomberg
Two Stocks That Have Deerfield Management And Anchor Bolt Capital Excited - Insider Monkey
大文字化:
|
ボリューム (24 時間):